ST. PAUL, Minn., July 2, 2013 /PRNewswire/ -- Prime Therapeutics (Prime), a leading pharmacy benefit manager (PBM), announced today that it is adding 200 customer service positions at its contact center in Irving, Texas. The new employees will support the company's member growth in the Medicare, pharmacy home delivery and health care exchange businesses.
"Irving has been, and continues to be, an excellent market for the skill set we need to deliver a superior experience for our members," stated Glen Laschober, Prime's chief operating officer. "In return, the creation of 200 more professional jobs in Irving helps the local economy, making this a win-win for everyone."
Customer service representatives will handle incoming calls from members. They will assist and support members and participating pharmacy networks by communicating information regarding their benefit plans, assuring they are satisfied and their claims are being processed accurately.
Prime currently employs over 600 professionals in its Irving location. In addition to customer service representatives, the facility houses pharmacists, pharmacy technicians, contact center supervisors, finance, human resources and IT staff.
Prime is seeking to fill these positions immediately, with start dates ranging from August 5 to October 7. All job openings in the Irving office are posted on the Prime Careers website.
About Prime Therapeutics
Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime manages pharmacy benefits for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and delivers medicine to members, offering clinical services for people with complex medical conditions. Headquartered in St. Paul, Minn., Prime serves more than 21 million people. It is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Prime has been recognized as one of the fastest-growing private companies in the nation.
For more information, visit www.primetherapeutics.com or follow @Prime_PBM on Twitter.
SOURCE Prime Therapeutics